Remove Capital Remove Funding Remove Layoffs Remove Platform
article thumbnail

The Station: Via hits $2.25B valuation, letters from readers, layoffs in a time of COVID-19

TechCrunch LA

This week, we’ll highlight Via’s Series E funding round that was led by Exor. The remaining $200 million came from new investors Macquarie Capital, Mori Building and Shell, as well as existing investors 83North, Broadscale Group, Ervington Investments, Hearst Ventures, Planven Ventures, Pitango and RiverPark Ventures.

Layoffs 136
article thumbnail

Glossier just laid off one-third of its corporate employees, mostly in tech

TechCrunch LA

W]e are shifting our technology strategy to leverage external partners for parts of our platform that we’re currently maintaining internally,” Weiss wrote in the email announcing the layoffs to staff. The tech team layoffs are notable for a beauty retailer that has often described itself as a technology company.

CTO Hire 197
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Down bad

TechCrunch LA

Last week, we talked about layoffs and the Winklevoss rock gods. This week, we saw the interconnectedness of major institutions as crypto lending protocol Celsius stuttered and brought down Ethereum prices with it as investors feared a price collapse brought on by reportedly over-leveraged players like 3 Arrows Capital. crash redux.

article thumbnail

Manufacturing startup Divergent 3D reduces staff by one-third

TechCrunch LA

The company developed an additive manufacturing platform designed to make it easier and faster to design and build new cars at a fraction of the cost — all while reducing the environmental impact that traditional factories have. Divergent 3D made Blade — which was on the auto show circuit in 2016 — to demonstrate the technology platform.

Startup 251
article thumbnail

Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More

Xconomy

In a week of big personnel moves, none was more surprising than Editas Medicine CEO Katrine Bosley’s departure.

Guide 63